GlassScriptPhysician profile
Wen-Shin Lee
NPI 1184068496
$4,810.12
in general payments reported to CMS, 2019-2025
16 companies · $931 in 2025
The $931 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $130 · 2021: $296 · 2022: $2,456 · 2023: $368 · 2024: $347 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $2,372.25 | 2019-2024 | Omni Surgical System |
| Alcon Vision LLC | $1,322.54 | 2019-2025 | Clareon, Hydrus Microstent, Voyager Dslt |
| Glaukos Corporation | $345.29 | 2025 | Idosetr |
| Abbvie INC. | $177.75 | 2025 | |
| Aerie Pharmaceuticals, INC. | $147.99 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $127.35 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $76.27 | 2022-2023 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $60.88 | 2025 | Vyzulta, Miebo |
| Allergan, INC. | $49.71 | 2019 | |
| Thea Pharma INC. | $23.17 | 2025 | Iyuzeh |
| Ivantis, INC | $20.03 | 2021 | |
| Ocular Therapeutix, INC. | $19.69 | 2025 | Dextenza |
| Rayner Intraocular Lenses Limited | $19.29 | 2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Amgen INC. | $19.01 | 2025 | Tepezza |
| Biotissue Holdings INC. | $15.36 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $13.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wen-Shin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.